ALTEOGEN revenue and financials
₩260,500.00Change from previous close: +0.19%Absolute change: +₩500.00
In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +109.87%
- 2025 vs 2024
- Net income growth
- +127.57%
- 2025 vs 2024
- Net margin
- 65.6%
- 2024: 60.5%
Financial data
Amounts in millions of KRW; per-share values in KRW; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 124,127 | 53,044 | -7,766 | -17,875 | — |
| Depreciation and amortization | 5,489 | 2,850 | 3,334 | 2,654 | — |
| Capital expenditure | -33,417 | -24,447 | -40,474 | -42,492 | — |
| Investing cash flow | -231,120 | -107,771 | -9,343 | 50,213 | — |
| Financing cash flow | 155,645 | 43,259 | 1,737 | 2,919 | — |
| Share repurchases | -1,366 | — | — | -557 | -795 |
| Debt issued | — | 10,000 | 1,710 | 1,000 | 750 |
| Debt repaid | -5,000 | — | -4,072 | -416 | -1,000 |
| Effect of exchange rates | -1,265 | 263 | -257 | 31.8 | — |
| Net change in cash | 48,652 | -11,468 | -15,372 | 35,257 | — |
| Free cash flow | 90,710 | 28,598 | -48,239 | -60,366 | — |